The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.42
Bid: 4.42
Ask: 4.46
Change: 0.02 (0.45%)
Spread: 0.04 (0.905%)
Open: 4.515
High: 4.515
Low: 4.38
Prev. Close: 4.40
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant Approval

14 Aug 2006 10:57

Seeing Machines Limited14 August 2006 14 August 2006 SEEING MACHINES LIMITED ("Seeing Machines" or "the Company") AUSTRALIAN GOVERNMENT APPROVES GRANT APPLICATION Seeing Machines Limited (AIM: SEE), a leading developer of advanced computerbased imaging software systems, has been advised by AusIndustry that itsapplication for an Australian Federal Government Commercial Ready Grantsupporting its glaucoma diagnostic device development project has been approved,conditional on finalising normal contractual arrangements. The grant providesmatching funding of up to AUD$2.1 million over 2 years to support the continueddevelopment and commercialization of the glaucoma device. Seeing Machines' glaucoma device is a non-contact objective device designed toreliably and quickly measure a person's functional visual field. Assessingvisual field is crucial in diagnosing a range of human visual system diseases,such as glaucoma. The key advantages the Seeing Machines device has over thoseavailable on the market today are derived from the objectivity of the technique.It is non-contact, fast and greatly enhances the patient experience. Seeing Machines completed an initial research and development project for thedevice in February 2006 and this work was supported by a $250,000 AusIndustryBiotechnology Innovation Fund Grant. The company has successfully completed(June 2006) a $3.2 million R&D Start Grant project aimed at developing SeeingMachines' face and eye tracking technology to a level where deployment in theautomotive domain for the detection of fatigue and distraction is feasible. Seeing Machines CEO Nick Cerneaz said: "the Company was very pleased to beawarded the Commercial Ready Grant. The strong endorsement of our technology, R&D capabilities and the potential for successful commercialisation of thisdevice is very encouraging." He also commented on the importance of governmentprograms supporting innovation for local industry development and noted thestrong support the company had received over the years for its R&D both fromCommonwealth and local government programs. Federal Industry Minister Ian Macfarlane congratulated Seeing Machines on beingoffered the Australian Government Commercial Ready grant to develop the devicethat will make it easier to diagnose diseases affecting vision: "Diseases such as glaucoma afflict millions of people world-wide and it isdifficult to detect. Seeing Machines has a strong track record in developingtechnology in this field and the Government, through the Commercial Readyprogram, is pleased to support projects such as this." Enquiries:Seeing Machines Limited Insinger de Beaufort Parkgreen Communications Nick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713www.seeingmachines.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th May 202011:05 amRNSSecond Price Monitoring Extn
6th May 202011:00 amRNSPrice Monitoring Extension
5th May 20204:41 pmRNSSecond Price Monitoring Extn
5th May 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20201:53 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSDirector/PDMR Shareholding
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:35 pmRNSPrice Monitoring Extension
2nd Apr 20202:06 pmRNSSecond Price Monitoring Extn
2nd Apr 20202:00 pmRNSPrice Monitoring Extension
2nd Apr 202011:00 amRNSPrice Monitoring Extension
1st Apr 20204:40 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 20207:00 amRNSAutomotive License Deal
20th Mar 202011:06 amRNSSecond Price Monitoring Extn
20th Mar 202011:01 amRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 202011:05 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSCOVID-19 Update
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20207:00 amRNSHalf year results to 31 December 2019
4th Mar 20207:00 amRNSAppointment of Joint Broker
30th Jan 20207:00 amRNSHalf year trading update
27th Jan 202010:52 amRNSHolding(s) in Company
13th Jan 20207:44 amRNSFOVIO Chip to display at Automotive World Tokyo
9th Jan 20207:00 amRNSSEE and Qualcomm Combine to Deliver DMS Technology
6th Jan 20207:00 amRNSSEE to showcase DMS technology at CES 2020
6th Jan 20207:00 amRNSFOVIO Chip optimized for NCAP readiness
16th Dec 201910:38 amRNSHolding(s) in Company
28th Nov 20198:00 amRNSResult of AGM
22nd Nov 20199:44 amRNSHolding(s) in Company
20th Nov 20199:31 amRNSUS NTSB Recommends Driver Monitoring
13th Nov 20197:00 amRNSBoard Changes - Seeing Machines Appoints New NEDs
11th Nov 20199:58 amRNSEuropean Council Adopts Enhanced Safety Regulation
8th Nov 20191:28 pmRNSHolding(s) in Company
7th Nov 20199:50 amRNSCapital Markets Day Presentation
6th Nov 20197:00 amRNSBusiness Update
30th Oct 20197:00 amRNSNotice of AGM
25th Oct 20197:00 amRNSFleet deal with North America's Safest Fleet
22nd Oct 201911:34 amRNSShare Transfer and Issue of Performance Rights
11th Oct 201912:00 pmRNSHolding(s) in Company
2nd Oct 20197:33 amRNSCollaboration with Alaska Airlines
1st Oct 201910:14 amRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSCEO Long Term Incentive Plan
27th Sep 201911:50 amRNSHolding(s) in Company
23rd Sep 20197:00 amRNSYear End Results
19th Sep 20199:18 amRNSWebcast Presentation - Year End Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.